CARDURA® XL (doxazosin mesylate extended release tablets)
Indicated for the treatment of both the urinary outflow obstruction and obstructive and irritative symptoms associated with BPH: hesitation, intermittency, dribbling, weak urinary stream, incomplete emptying of the bladder, nocturia, daytime frequency, urgency and burning.
Features:
- Extended release
- Tablets/capsules
Dosage:
1mg to 8mg daily or 1mg to 16mg daily.
Active Ingredients:
Doxazosin mesylate.
Post new comment